Mr. Voigts said, "The launch of Renú® in Europe for aesthetics medicine represents a key milestone for our company and we are committed to successfully bringing this product to market in the United States, South America, and Asia-Pacific in the future."
Mr. Milo said, "We are thrilled to introduce our Renú® product to plastic and reconstructive surgeons, and dermatologists, in Europe at the prestigious IMCAS World Congress, and I am looking forward to meeting many of the physicians and industry professionals at the conference." He added, "We are also looking for physicians in the EU to aid in PMCF studies and investigators for our US clinical study."
"We will be announcing a special introductory price for Renú® at the IMCAS congress and I am delighted to have the opportunity to present our product to physicians and distributors at the exhibit," said Mr. Renten.
About RegenScientific - Cytophil, Inc.:
RegenScientific, a wholly-owned business unit of Cytophil, Inc., is dedicated to providing physicians and patients with high-quality, safe, efficacious, and cost-effective soft tissue augmentation implants. The company has CE-Mark for its Renú® Soft Tissue Volumizing Filler for lipoatrophy, vocal fold insufficiency, and soft tissue augmentation in Europe. The company has FDA 510k clearances for its Renú® Gel and Renú® Voice otolaryngology products indicated for vocal fold injection augmentation. Renú® is a registered trademark of Cytophil, Inc. REGENSCIENTIFIC™ and the REGENSCIENTIFIC logo are trademarks of Cytophil, Inc.
Contact RegenScientific - Cytophil, Inc.:
Charles F. Milo, MBA
Chief Business Officer
Tel: (262) 215-6779
Email: [email protected]
Ron Renten
VP of Sales and Marketing, EMEA
Tel: +31 (0) 6 51 33 87 22
Email: [email protected]
www.regenscientific.com
Photo - http://photos.prnewswire.com/prnh/20160120/324423
Logo - http://photos.prnewswire.com/prnh/20150527/218707LOGO
SOURCE RegenScientific
Related Links
http://www.regenscientific.com
Share this article